Lipidome in colorectal cancer
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
// Guifang Yan 1,* , Liqi Li 2,* , Bo Zhu 1 and Yongsheng Li 1,3 1 Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China 2 Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China 3 Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA * These authors contributed equally to this work Correspondence to: Bo Zhu, email: // Yongsheng Li, email: // Keywords : lipidome, metabolism, colorectal cancer, fatty acid, cholesterol Received : December 07, 2015 Accepted : February 25, 2016 Published : March 07, 2016 Abstract Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Understanding its pathophysiology is essential for developing efficient strategies to treat this disease. Lipidome, the sum of total lipids, related enzymes, receptors and signaling pathways, plays crucial roles in multiple cellular processes, such as metabolism, energy storage, proliferation and apoptosis. Dysregulation of lipid metabolism and function contributes to the development of CRC, and can be used towards the evaluation of prognosis. The strategies targeting lipidome have been applied in clinical trails and showed promising results. Here we discuss recent advances in abnormal lipid metabolism in CRC, the mechanisms by which the lipidome regulates tumorigenesis and tumor progression, and suggest potential therapeutic targets for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Prentice, R. L., Caan, B., Chlebowski, R. T., Patterson, R., Kuller, L. H., Ockene, J. K., Margolis, K. L., Limacher, M. C., Manson, J. E., Parker, L. M., et al. (2006) · JAMA · doi:10.1001/jama.295.6.629 · Cited by 828
Seril, D. N. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.353 · Cited by 467
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357 · cited 1×
“Moreover, LXRα-null and FXR-null mice with highcholesterol intake develop massive hepatic accumulation of cholesterol, while wild-type mice are resistant to cholesterol feeding [61, 62].”
BackgroundAnticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Cockbain, A. J., Volpato, M., Race, A. D., Munarini, A., Fazio, C., Belluzzi, A., Loadman, P. M., Toogood, G. J., & Hull, M. A. (2014) · Gut · doi:10.1136/gutjnl-2013-306445 · Cited by 115 · cited 1×
“A Phase II doubleblind, placebo-controlled trial of EPA-FFA in patients undergoing liver resection surgery for CRC liver metastases (CRCLM) showed that EPA-FFA therapy has antiangiogenic properties and is safe and well tolerated [90].”
Background
Cited by
Cell membrane modulation as adjuvant in cancer therapy
Zalba, S., & ten Hagen, T. L. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.008 · Cited by 365
Trapecar, M., Communal, C., Velazquez, J., Maass, C. A., Huang, Y.-J., Schneider, K., Wright, C. W., Butty, V., Eng, G., Yilmaz, O., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.02.008 · Cited by 218
Lipid metabolism as a targetable metabolic vulnerability in colorectal cancer
Zaytseva, Y. (2021) · Cancers · doi:10.3390/cancers13020301 · Cited by 53
“Multiple studies have corroborated the association between CRC and alterations in lipids [9,10], demonstrating that lipid metabolism has a profound impact on CRC initiation and progression and is a targetable vulnerability in this disease.”
BackgroundThe Role of ATP-Binding Cassette Subfamily A in Colorectal Cancer Progression and Resistance
Alketbi, L., Al-Ali, A., Talaat, I. M., Hamid, Q., & Bajbouj, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021344 · Cited by 20
Metadata
- Authors
- Yan, G., Li, L., Zhu, B., & Li, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-03-07
- Volume
- 7
- Issue
- 22
- Pages
- 33429-33439
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2295380953
- Cited by
- 72
- References
- 7
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipidome in colorectal cancer. https://app.cochat.ai/papers/10.18632/oncotarget.7960
- The paper
- Yan, G., Li, L., Zhu, B., & Li, Y. (2016). Lipidome in colorectal cancer. Oncotarget. https://doi.org/10.18632/oncotarget.7960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.